NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Formycon AG Logo
A biopharmaceutical company developing high-quality biosimilars for complex medicines.
Germany
FYB
Forte Biosciences, Inc. Logo
A clinical-stage biopharma firm developing treatments for autoimmune-related diseases.
United States of America
FBRX
Fortress Biotech, Inc. Logo
Biopharmaceutical firm that develops and commercializes a diversified drug portfolio.
United States of America
FBIO
FRACTYL HEALTH, INC. Logo
Develops therapies targeting the root causes of obesity and type 2 diabetes.
United States of America
GUTS
Friulchem Logo
A contract development and manufacturing organization for the animal health sector.
Italy
FCM
Fuji Pharma Co.,Ltd. Logo
Pharmaceutical firm focused on women's healthcare and contract manufacturing services.
Japan
4554
Fulcrum Therapeutics, Inc. Logo
Develops small molecule therapies for rare, genetically defined diseases.
United States of America
FULC
FunPep Company Limited Logo
Develops therapeutic solutions derived from functional peptides.
Japan
4881
Fuso Pharmaceutical Industries,Ltd. Logo
Develops and manufactures pharmaceuticals, focusing on infusions and dialysis solutions.
Japan
4538
FUTURA MEDICAL PLC Logo
Pharmaceutical company developing topical gel formulations for sexual health.
United Kingdom
FUM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.